ORY-2001

· Oryzon Genomics S.A.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ORY-2001, covering 2021-03-05 to 2021-03-05. Get the full timeline:

Most recent: Clinical Trial Update: Testing the Safety and Preliminary Efficacy of the New Drug ORY-2001 in Mild to Moderate Alzheimer's Disease [Phase 2]

See pricing